<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597687</url>
  </required_header>
  <id_info>
    <org_study_id>115741</org_study_id>
    <nct_id>NCT01597687</nct_id>
  </id_info>
  <brief_title>Pertussis Infection in Adolescents and Adults With Prolonged Cough</brief_title>
  <official_title>Bordetella Pertussis Infection Among Adolescents and Adults With Prolonged Cough</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      This study aims to determine the burden of pertussis infection among adolescents and adults
      with prolonged cough in four Asian countries, namely Malaysia, Philippines, Taiwan and
      Thailand. This study also aims to assess the health economic (HE) impact of pertussis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data from this cross-sectional study will be useful in reviewing the need for introduction of
      booster doses of pertussis vaccines in adolescent and adult population in Malaysia,
      Philippines, Taiwan and Thailand.

      This study will enrol patients with prolonged cough of 2 weeks or more and detect pertussis
      with serological tests in order to estimate the prevalence of pertussis infection among such
      patients. No vaccine will be administered during this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serological evidence of pertussis infection among adolescents aged 13-18 years and adults aged &gt;18 years, defined as anti-pertussis toxin (PT) IgG level indicative of active or recent infection.</measure>
    <time_frame>During the study period (Approximately 1 year)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of clinical features of subjects, including paroxysm, whoop, night cough, cyanosis, fever and post-tussive vomiting.</measure>
    <time_frame>During the study period (Approximately 1 year)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of health economical impact.</measure>
    <time_frame>During the study period (Approximately 1 year)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the impact of pertussis on quality of life of patients.</measure>
    <time_frame>During the study period (Approximately 1 year)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">337</enrollment>
  <condition>Pertussis</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adolescents aged 13-18 years and adults aged &gt;18 years with prolonged cough of 2 weeks or more.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood collection</intervention_name>
    <description>1 blood sample will be collected from each subject.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Quality of Life and HE questionnaires.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adolescents aged 13-18 years or adults aged &gt;18years.

          -  Presenting with prolonged cough of 2 weeks (14 days) or more.

          -  Subjects who the investigator believes that they/ their parent(s)/Legally Acceptable
             Representative(s) [LAR(s)] can and will comply with the requirements of the protocol.

          -  Written informed consent obtained from the subject/ from the parent(s)/LAR of the
             subject. If the subject below the age of consent is legally eligible, his/her
             signature on the informed assent form should be obtained.

        Exclusion Criteria:

          -  Child in care.

          -  Subjects with known chronic cough-causing disease and immunodeficiency.

          -  Subjects treated with angiotensin-converting enzyme inhibitors (ACEI), within the past
             4 weeks (28 days).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Seremban</city>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taichung</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Songkla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
    <country>Taiwan</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2012</study_first_posted>
  <last_update_submitted>November 7, 2013</last_update_submitted>
  <last_update_submitted_qc>November 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pertussis infection</keyword>
  <keyword>Prevalence</keyword>
  <keyword>health economic burden</keyword>
  <keyword>prolonged cough</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Whooping Cough</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 11, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

